Navigation Links
Castor Bean Genome Published by Research Team Including Scientists from the Venter Institute
Date:8/22/2010

The JCVI is a not-for-profit research institute in Rockville, MD and La Jolla, CA dedicated to the advancement of the science of genomics; the understanding of its implications for society; and communication of those results to the scientific community, the public, and policymakers. Founded by J. Craig Venter, Ph.D., the JCVI is home to approximately 400 scientists and staff with expertise in human and evolutionary biology, genetics, bioinformatics/informatics, information technology, high-throughput DNA sequencing, genomic and environmental policy research, and public education in science and science policy. The legacy organizations of the JCVI are: The Institute for Genomic Research (TIGR), The Center for the Advancement of Genomics (TCAG), the Institute for Biological Energy Alternatives (IBEA), the Joint Technology Center (JTC), and the J. Craig Venter Science Foundation. The JCVI is a 501 (c) (3) organization. For additional information, please visit http://www.JCVI.org.


'/>"/>
SOURCE J. Craig Venter Institute
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. CJP Assesses Pongamia, Moringa, Castor, Simarouba, Algae etc. as New Sustainable Biodiesel Crops
2. Caringo Delivers Storage Cluster in a Box with CAStor 3.0
3. Canadas Michael Smith Genome Sciences Center Validates NEBNext™ DNA Sample Preparation Reagents From New England Biolabs for Use in Next Generation Sequencing
4. Sequencing of the human body louse genome
5. Multinational Research Team Led by J. Craig Venter Institutes Ewen Kirkness Sequence Body Louse Genome
6. Cellectis bioresearch Establishes The Genome Customization Award (TGCA)
7. Cellectis to Present at the FASEB Summer Research Conference on Genome Engineering
8. Launch of GenoCon: First-ever Contest in Rational Genome Design Based on Semantic-web Technology
9. Scientists boot up a bacterial cell with a synthetic genome
10. GenomeQuest & Thomson Reuters Host IP Seminar
11. Hypertensive rat genome sequence expected to uncover genetic basis of human hypertension
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)... 2013 First patients dosed with ... bromide designed using Prosonix, particle engineering platform ... of inhaled Respiratory Medicines by Design , has ... will assess its effect on lung function and the ... moderate to severe chronic obstructive pulmonary disease (COPD). The ...
(Date:5/21/2013)... MA (PRWEB) May 21, 2013 ... tracking to reporting eLearning solution using Tin Can ... and dashboard tool. CLD is a leading developer ... and medical device companies worldwide. , Tin ... standard that helps learners and trainers more accurately ...
(Date:5/21/2013)... 21, 2013 Alpha Source, Inc., ... will be exhibiting for the 13th consecutive year ... Instrumentation (AAMI) 2013 Conference and Expo. The conference ... and manufacture healthcare technologies. This year’s event will ... California. , The three-day event draws over ...
(Date:5/21/2013)... Clinverse, Inc. , a ... trials, announced today it has formed a strategic ... ClinPay® FLS eClinical commerce platform aggregates data collected ... SpendMD ™, Aggregate Spend Solutions’ recently-launched flagship product, ... reporting transfer of value at investigator meetings or ...
Breaking Biology Technology:Prosonix Initiates Phase 2 Clinical Study with PSX1002 in Patients with Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) 2Prosonix Initiates Phase 2 Clinical Study with PSX1002 in Patients with Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) 3Prosonix Initiates Phase 2 Clinical Study with PSX1002 in Patients with Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) 4CLD Integrates Tin CAN API with its eLearning Solutions and Launches its Excelerometer Tracking Statement Dashboard 2CLD Integrates Tin CAN API with its eLearning Solutions and Launches its Excelerometer Tracking Statement Dashboard 3Alpha Source, Inc. to Exhibit at the AAMI 2013 Conference and Expo 2Clinverse, Inc. Announces Strategic Alliance with Aggregate Spend Solutions, LLC 2Clinverse, Inc. Announces Strategic Alliance with Aggregate Spend Solutions, LLC 3
... Quark Pharmaceuticals, Inc.,a development-stage pharmaceutical company ... therapeutics, today announced the,presentation of posters ... taking place,September 16-18, 2008 in Stockholm, ... Hagar Kalinski, and Hagit Ashush, presented ...
... 17 Dendreon Corporation,(Nasdaq: DNDN ) today announced ... of Dendreon, will present a company update at the,UBS ... Monday, September,22, 2008 at 1:30 p.m. ET., A ... through the,Investor Relations section of the Dendreon website, http://www.dendreon.com ...
... China, Sept. 17 /Xinhua-PRNewswire-FirstCall/ --,China Biologic Products, ... the "Company"), one of the leading plasma-based ... ("PRC"), today announced that the Company,received approval ... Administration (the,"SFDA") to commence clinical trial of ...
Cached Biology Technology:Quark Pharmaceuticals Announces Poster Presentations at RNAi Europe 2008 2Quark Pharmaceuticals Announces Poster Presentations at RNAi Europe 2008 3China Biologic Receives SFDA Approval for Clinical Trial of Human Coagulation Factor VIII 2China Biologic Receives SFDA Approval for Clinical Trial of Human Coagulation Factor VIII 3
(Date:5/21/2013)... Mo. Cancers of all types become most deadly ... Once cancer has reached this stage, it becomes very ... tumors that can develop. Now, researchers at the University ... nanoparticles that target lymphoma tumor cells wherever they may ... of oncology in the MU College of Veterinary Medicine, ...
(Date:5/21/2013)... Society (ACS), the world,s largest scientific society, invites ... & Exposition, September 8-12, 2013, in Indianapolis, Ind. ... Center and at area hotels. , With more ... science,s horizons from astronomy to zoology ― ... journalists a rich assortment of spot news and ...
(Date:5/21/2013)... epigenetic modifications, which alter the way genes function ... be detected in the blood of pregnant women ... to foretell depression in the weeks after giving ... become debilitating. , The findings of the small ... in the journal Molecular Psychiatry . , ...
Breaking Biology News(10 mins):MU researchers develop radioactive nanoparticles that target cancer cells 2Genetic predictors of postpartum depression uncovered by Hopkins researchers 2Genetic predictors of postpartum depression uncovered by Hopkins researchers 3
... of plants genetically tweaked to absorb more contaminants, researchers ... wild-type counterparts. The results raised hopes that the plants ... soil. , The new research findings, published Feb. 1 ... three transgenic lines of the Indian mustard plant, Brassica ...
... of Cell Metabolism has provided insight into a key ... suggests a novel approach to the development of cholesterol-lowering ... of the most prescribed cholesterol inhibitors, according to researchers ... Cells obtain cholesterol, an important component of cell membranes, ...
... Washington Alaska Salmon Program, the world's longest-running effort to ... million from the Gordon and Betty Moore Foundation to ... program has applications for Pacific salmon all along the ... salmon runs and their management. , The grant boosts ...
Cached Biology News:Transgenic plants remove more selenium from polluted soil than wild plants, new tests show 2Transgenic plants remove more selenium from polluted soil than wild plants, new tests show 3Transgenic plants remove more selenium from polluted soil than wild plants, new tests show 4Insight into natural cholesterol control suggests novel cholesterol-lowering therapy 2Alaskan puzzles, monitoring provide insight about North Pacific salmon runs 2
DTT 50 l...
...
Rabbit polyclonal to Staphylococcus Enterotoxin E (Biotin) ( Abpromise for all tested applications)....
Chicken polyclonal to YebU ( Abpromise for all tested applications). Antigen: Synthetic peptide, corresponding to amino acids 196-244 of E. coli YebU....
Biology Products: